News
-

Eczema Camps for Children
Eczema camps are now an option for families. They offer a tailored experience for children with eczema and other skin diseases.
-

RSV Vaccines Are Now Available
The FDA has approved respiratory syncytial virus (RSV) vaccines for older adults and an RSV monoclonal antibody for infants and young children.
-

Allergy & Asthma Network Applauds FAA Bill to Update Airline Emergency Medical Kits
Airline Emergency Medical Kits should include epinephrine to ensure passengers are treated for severe or life-threatening allergic reactions.
-

Maryland Becomes 23rd State to Adopt Stock Albuterol in Schools
Stock albuterol laws allow schools to store and administer emergency supplies of quick-relief albuterol inhalers.
-

Teva to Discontinue Digital Inhalers
Asthma patients who use one of Teva’s three Digihaler devices should talk wit their doctor about alternatives.
-

Allergy & Asthma Network Commends EPA for Stronger Car Emission Standards
The new EPA standards for vehicles will help protect respiratory health and address climate change.
-

FDA Approves Xolair as First Treatment to Reduce Risk of Food Allergy Reactions
Learn about a research study looking into the use of a biologic to determine if it can aid food allergy oral immunotherapy.
-

New Asthma Inhaler Combines Quick-Relief Albuterol and Corticosteroid
A new medication supports treating asthma symptoms and inflamed airways in the short and long term using one inhaler device.
-

Is There a Link Between Migraine Headaches, Asthma, and Allergies?
People who experience occasional migraine headaches may be at greater risk of developing chronic migraine headaches if they also have asthma.
-

Asthma Equity Explorer Advances Asthma Research Into Disparities
Asthma Equity Explorer is a free web-based database for asthma research. See how asthma prevalence in the US can lead to health disparities.
-

Allergy & Asthma Day Capitol Hill 2024: Advocating for Health Equity
At our 27th annual advocacy day, we connected with members of Congress and supported people living with asthma, allergies, and related conditions.
-

COVID Antiviral Pill
The COVID-19 pill is considered a major step forward in managing COVID-19. Two COVID-19 antiviral pills are currently available. Updated: January 5, 2024
All About
News
Allergy & Asthma Network keeps you up to date with the latest news, information and patient education addressing asthma, allergies and related conditions. Read the latest press releases and learn about our initiatives in advocacy on the federal, state and local levels. Get information on the Network’s research projects and how you can get involved.









